Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mervyn GlaxoSmithKline Thompson is active.

Publication


Featured researches published by Mervyn GlaxoSmithKline Thompson.


Archive | 2003

Vanilloid receptor modulators

Gregor James GlaxoSmithKline Macdonald; Darren Jason Mitchell; Harshad Kantilal GlaxoSmithKline Rami; Mervyn GlaxoSmithKline Thompson; Susan Marie Westaway


Archive | 2002

Urea-compounds active as vanilloid receptor antagonists for the treatment of pain

Harshad Kantilal GlaxoSmithKline Rami; Mervyn GlaxoSmithKline Thompson; Paul Adrian GlaxoSmithKline Wyman


Archive | 2002

3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders

Steven Mark GlaxoSmithKline SpA Bromidge; Christopher Norbert GlaxoSmithKline Johnson; Gregor James GlaxoSmithKline Macdonald; Mervyn GlaxoSmithKline Thompson; David R. Witty


Archive | 2002

7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders

Mahmood Ahmed; Steven Mark GlaxoSmithKline SpA Bromidge; Ian Thomson GlaxoSmithKline Forbes; Andrew Derrick GlaxoSmithKline Gribble; Christopher Norbert GlaxoSmithKline Johnson; Francis David GlaxoSmithKline King; Andrew P. Lightfoot; Gregor James GlaxoSmithKline Macdonald; Stephen Frederick Moss; Mervyn GlaxoSmithKline Thompson; David R. Witty


Archive | 2004

Urea derivatives having vanilloid receptor antagonist activity

Gregor James GlaxoSmithKline Macdonald; Harshad Kantilal GlaxoSmithKline Rami; Mervyn GlaxoSmithKline Thompson


Archive | 2003

Quinoline and aza-indole derivatives and their use as 5-ht6 ligands

Christopher Norbert GlaxoSmithKline Johnson; Gregor James GlaxoSmithKline Macdonald; Darren Jason Mitchell; Stephen Frederick Moss; Mervyn GlaxoSmithKline Thompson; David R. GlaxoSmithKline Witty


Archive | 2005

3-Arylsulfonyl-Quinolines as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders

Christopher Norbert GlaxoSmithKline Johnson; Geoffrey GlaxoSmithKline Stemp; Mervyn GlaxoSmithKline Thompson; David Richard Witty


Archive | 2003

QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS

Mahmood Ahmed; Christopher Norbert GlaxoSmithKline Johnson; Martin Jones; Gregor James GlaxoSmithKline Macdonald; Stephen Frederick Moss; Mervyn GlaxoSmithKline Thompson; Charles Edward Wade; David R. GlaxoSmithKline Witty


Archive | 2007

Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases

Darren Jason Mitchell; Jonathan Thomas Seal; Mervyn GlaxoSmithKline Thompson; Susan Marie Westaway; Samantha Louisa Brown


Archive | 2004

Phenyl sulfone derivatives and their use in the treatment of cns disorders

Gregor James GlaxoSmithKline Macdonald; Mervyn GlaxoSmithKline Thompson

Collaboration


Dive into the Mervyn GlaxoSmithKline Thompson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge